According to Quick-Med Technologies, Nimbus is a next-generation antimicrobial technology that is non-leaching, non-toxic, long-lasting and not blocked by organics such as blood, urine and perspiration.
Ladd Greeno, CEO of Quick-Med Technologies, said: “We are excited to team with Avery Dennison to incorporate our advanced Nimbus technology in adhesives. This collaboration will leverage Nimbus technology to a next generation of antimicrobial adhesives to address growing infection concerns.”